Clinical Trials Browser

NCT05957042 2025-12-10

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms

NCT06246786 2025-07-16

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Phase EARLY_PHASE1 Withdrawn

Breast

Triple Negative Breast Neoplasms

NCT03473691 2024-12-09

Breast50

Phase EARLY_PHASE1 Withdrawn

Breast

Triple Negative Breast Neoplasms

NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT05465590 2023-12-21

A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms

NCT05436808 2023-10-18

Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05368506 2023-05-06

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

Phase EARLY_PHASE1 Withdrawn

BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT04249167 2023-01-06

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast

Triple Negative Breast Neoplasms

NCT04630210 2022-06-15

AteBrO

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms

NCT03295695 2020-12-04

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT04088032 2020-07-16

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Phase EARLY_PHASE1 Withdrawn

BreastOther neoplasm

Breast Cancer Female

NCT03388814 2018-11-30

Speeding Recovery From Pain and Opioid Use

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms, Pain, Postoperative

NCT00993642 2017-03-13

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms

NCT01302002 2016-02-23

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms

NCT00606970 2013-05-07

Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms

NCT01055678 2012-12-17

To Evaluate the Characteristics of a Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular